Community Doctors’ Understanding of Pneumococcal Vaccine before and after the Education_West China Medical Journal

Authors：

LI Jun ,  DONG Birong , SHU Defen

Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

DONG Birong, Email: jundream2003@yahoo.com.cn

Keywords：

肺炎球菌疫苗; 社区医生; 培训; 老年人群

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

【摘要】　目的　应用调查问卷分析培训前后成都市社区医生对肺炎球菌疫苗的认识，为推动社区肺炎球菌疫苗接种奠定基础。　方法　对215名成都市社区医生进行肺炎球菌疾病及预防知识的培训，并在培训前后行问卷调查，回收问卷并分析。　结果　经培训，社区医生提高了对肺炎球菌疾病及疫苗接种知识的掌握程度，加深了对肺炎球菌疾病及疫苗接种重要性的认识。　结论　对社区医生进行肺炎球菌相关知识的培训，有利于提高社区医生对肺炎球菌疫苗接种推荐的专业性和成功率。
【Abstract】　Objective　 To know the community doctors’ understanding of pneumococcal vaccine before and after the education via questionnaire. 　Methods　 A total of 215 community doctors in Chengdu were educated in pneumococcal disease and the prevention knowledge. Questionnaire investigation was performed before and after the education and the results were analyzed.　Results　 After the education, the acknowledgement of pneumococcal vaccination of the community doctors was improved.　Conclusion　 The education of the knowledge of pneumococcal vaccine for the community doctors helps to improve the acknowledgement of pneumococcal vaccination.

Citation： LI Jun,DONG Birong,SHU Defen. Community Doctors’ Understanding of Pneumococcal Vaccine before and after the Education. West China Medical Journal, 2011, 26(1): 38-40. doi: Copy

1.	Cripps AW, Leach AJ, Lehmann D. Pneumococcal vaccination in developing countries[J]. Lancet, 2006, 19, 368(9536): 644.
2.	Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations[J]. JAMA, 1993, 270(15): 1826-1831.
3.	WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2007, 82(12): 93-104.
4.	WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2008, 83(42): 373-384.
5.	Christenson B, Hedlund J, Lunbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons[J]. Eur Respir J, 2004, 23(3): 363-368.
6.	Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity[J]. Virol J, 2008, 5: 52.
7.	徐英, 董碧蓉. 23价肺炎球菌多糖疫苗预防老年人下呼吸道感染的效果考察[J]. 中国计划免疫, 2005, 11(4): 287-291.
8.	Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial[J]. Lancet, 2005, 365(9465): 1139-1146.
9.	Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection[J]. N Engl J Med, 2003, 349(14): 1341-1348.
10.	Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study[J]. Lancet, 2001, 357(9261): 1008-1011.
11.	WHO position paper. Pneumococcal vaccines[J]. Wkly Epidemiol Rec, 2003, 79(14): 110-119.
12.	Nichol KL, Zimmerman R. Generalist and subspecialist physicians’ knowledge, attitudes and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients[J]. Arch Intern Med, 2001, 161 (22): 270-272.
13.	徐英, 董碧蓉. 老年人群接种多价肺炎球菌疫苗的临床免疫效果与经济效益[J]. 华西医学, 2003, 18(3): 442.

1. 　Cripps AW, Leach AJ, Lehmann D. Pneumococcal vaccination in developing countries[J]. Lancet, 2006, 19, 368(9536): 644.
2. 　Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations[J]. JAMA, 1993, 270(15): 1826-1831.
3. 　WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2007, 82(12): 93-104.
4. 　WHO position paper. 23-valent pneumococcal polysaccharide vaccine[J]. Wkly Epidemiol Rec, 2008, 83(42): 373-384.
5. 　Christenson B, Hedlund J, Lunbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons[J]. Eur Respir J, 2004, 23(3): 363-368.
6. 　Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity[J]. Virol J, 2008, 5: 52.
7. 　徐英, 董碧蓉. 23价肺炎球菌多糖疫苗预防老年人下呼吸道感染的效果考察[J]. 中国计划免疫, 2005, 11(4): 287-291.
8. 　Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial[J]. Lancet, 2005, 365(9465): 1139-1146.
9. 　Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection[J]. N Engl J Med, 2003, 349(14): 1341-1348.
10. 　Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study[J]. Lancet, 2001, 357(9261): 1008-1011.
11. 　WHO position paper. Pneumococcal vaccines[J]. Wkly Epidemiol Rec, 2003, 79(14): 110-119.
12. 　Nichol KL, Zimmerman R. Generalist and subspecialist physicians’ knowledge, attitudes and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients[J]. Arch Intern Med, 2001, 161 (22): 270-272.
13. 　徐英, 董碧蓉. 老年人群接种多价肺炎球菌疫苗的临床免疫效果与经济效益[J]. 华西医学, 2003, 18(3): 442.

West China Medical Journal

Community Doctors’ Understanding of Pneumococcal Vaccine before and after the Education

Abstract Full text Figures/Tables Video References Cited by

Format

Content